Privately held OncoQR ML, based in Vienna/Austria, is a pre-clinical biotech company that offers novel therapeutic cancer vaccines based on its unique, proprietary and broadly applicable S-TIR™ (Specific Total Immune Remodeler) technology platform. Unlike any other currently available therapy, the platform is capable of boosting the patient’s immune system to generate a strong, specific and controlled immune response against cancer. This “Active Checkpoint Control Immunotherapy” activates all four naturally available tumour killing mechanisms of the immune system without triggering side effects. The company’s lead candidate OQR100 (TYG100), co-developed with TYG Oncology Ltd. and CR-UK, targets pancreatic cancer and induces neutralizing antibodies against gastrin, a major growth factor for pancreatic- and other forms of gastric cancer. OQR200 is directed against HER2/neu over-expressing breast cancer and induces strong polyclonal humoral (IgG and IgA) and cellular (CD4 and CD8) immune responses, superior to trastuzumab, pertuzumab or passive checkpoint inhibitors. Both lead candidates, which have achieved in vivo Proof of Concept in non-human primates, as well as the S-TIR™ technology platform are now available for out-licensing. For further information visit www.oncoqr.com.
+ Cancer immunotherapy
+ Active therapy (protein/peptide based)
+ Checkpoint Control
+ No side effects
+ Activation of all 4 naturally available killing mechanisms of the immune system
+ Multiple cancer targets
Company Details
- Employees
- 3
- Founded
- -
- Address
- Mooslackengasse 17, Vienna,vienna 1190,austria
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- oncoqr.com
- Keywords
- Active Checkpoint Control Immunotherapy, Cancer Immunotherapy, Cancer Vaccine, Immunooncology, Life Science, S-TIR (TM) Technology.
- HQ
- Vienna, Vienna
Oncoqr Ml Gmbh Questions
Oncoqr Ml Gmbh's website is oncoqr.com
Oncoqr Ml Gmbh's LinkedIn profile is https://at.linkedin.com/company/oncoqr-ml-gmbh
Oncoqr Ml Gmbh has
3 employees.
View email and phone details for 3
employees at Oncoqr Ml Gmbh.
Oncoqr Ml Gmbh's industry is
Biotechnology Research
Oncoqr Ml Gmbh's top competitors are
Attoquant Diagnostics Gmbh,
S-Target Therapeutics,
Themis Bioscience Gmbh,
Aposcience Ag,
Apeiron Biologics Ag,
Panoptes Pharma Ges.m.b.h,
Improcess Gmbh,
Gh Bioquenta Consulting E.u.,
The Mannheimer Foundation, Inc.,
Mycoplasma Biosafety.
Oncoqr Ml Gmbh's categories are Biotechnology Research
Oncoqr Ml Gmbh's founding year is 2013
